Table 2 Prevalence of known risk factors for COVID-19 among adult patients with recent diagnosis of SUD (and its subtypes) (“Y”) versus adult patients without recent diagnosis of SUD (and its subtypes) (“N”).

From: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

  Asthma
(%)
CKD COPD
(%)
T2D
(%)
CLD
(%)
CVD
(%)
HP
(%)
Obesity
(%)
HIV Cancer
(%)
SUD
 Y 22.11 6.25 18.86 18.60 8.26 72.67 48.99 30.12 1.75 15.06
 N 6.89 1.03 1.63 4.64 1.20 23.34 13.02 7.23 0.27 3.83
AUD
 Y 17.86 5.77 16.86 14.91 12.61 73.61 53.77 21.38 2.35 14.41
 N 7.05 1.09 1.80 4.79 1.27 23.83 13.37 7.47 0.29 3.95
Cocaine-UD
 Y 25.77 10.09 22.03 20.73 16.34 75.45 51.33 25.56 4.90 10.37
 N 7.06 1.09 1.82 4.80 1.28 23.89 13.42 7.49 0.29 3.96
CUD
 Y 23.89 5.32 11.23 11.98 5.32 61.65 34.41 23.60 2.36 9.18
 N 7.05 1.09 1.82 4.80 1.09 23.89 13.42 7.49 0.29 3.96
OUD
 Y 23.93 7.60 17.63 17.44 7.60 71.49 46.35 26.75 1.70 15.98
 N 7.05 1.09 1.81 4.79 1.09 23.87 13.40 7.48 0.28 3.85
TUD
 Y 23.16 6.56 21.13 19.93 7.891 74.89 50.89 32.37 1.70 15.98
 N 6.91 1.04 1.64 4.66 1.22 23.42 13.07 7.26 0.28 3.85
  1. CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, T2D diabetes mellitus type 2, CLD chronic liver disease, CVD cardiovascular diseases, HP hypertension.